Heart Medicine

As per available reports about 100 journals, 162 Conferences, 30 workshops are presently dedicated exclusively to heart medicine and about 366282 articles are being published on the current trends in heart medicine. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to heart medicine are being carried out. As reported in 2013 American College of Cardiology/American Heart Association Guidelines on Treatment of Hypercholesterolemia, High-dose statins reduce serum low-density lipoprotein (LDL) cholesterol ≥ 50% and include atorvastatin 40 mg to 80 mg daily and rosuvastatin 20 mg to 40 mg daily. Moderate-dose statins reduce serum LDL cholesterol 30% to 49% and include atorvastatin 10 mg to 20 mg daily, rosuvastatin 5 mg to 10 mg daily, simvastatin 20 mg to 40 mg daily, pravastatin 40 mg to 80 mg daily, lovastatin 40 mg daily, fluvastatin XL 80 mg daily, fluvastatin 40 mg twice daily, and pitavastatin 2mg to 4 mg daily. Low-dose statins reduce serum LDL cholesterol less than 30% and include simvastatin 10 mg daily, pravastatin 10 mg to 20 mg daily, lovastatin 20 mg daily, fluvastatin 20 mg to 40 mg daily, and pitavastatin 1 mg daily. Patients with New York Heart Association class II, III, or IV heart failure and patients undergoing maintenance hemodialysis are unlikely to benefit from treatment from statins. The Journal of Clinical & Experimental Cardiology is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals in heart medicine. Each year research scientists have noticed a rise in the number of congresses being held in this field. The Journal of Clinical & Experimental Cardiology provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of heart medicine, thus bridging the gap between researchers and young scientists. OMICS International – a pioneer in organizing international conferences Cardiology International conference is designed to provide diverse and current education that will keep medical professionals abreast of the issues affecting the prevention, diagnosis and treatment of cardiovascular disease. Distinguished faculty will lead discussions on a variety of issues facing today’s cardiovascular providers such as Pediatric Heart Diseases, Cardiomyopathy, Angiogenesis, Pacemakers, Cardiac Rehabilitation, Statin Therapy, Pulmonary Stenosis, Atrial Fibrillation and Electrocardiography.